Dolan K - Search Results

1

Injecting risk behaviours following treatment for hepatitis C virus infection among people who inject drugs: The Australian Trial in Acute Hepatitis C.

Alavi M, Spelman T, Matthews GV, Haber PS, Day C, van Beek I, Walsh N, Yeung B, Bruneau J, Petoumenos K, Dolan K, Kaldor JM, Dore GJ, Hellard M, Grebely J; ATAHC Study Group. Alavi M, et al. Among authors: dolan k. Int J Drug Policy. 2015 Oct;26(10):976-83. doi: 10.1016/j.drugpo.2015.05.003. Epub 2015 May 21. Int J Drug Policy. 2015. PMID: 26115881 Free PMC article. Clinical Trial.

2

HIV prevalence and risk behaviour in needle exchange attenders: a national study. The Collaboration of Australian Needle Exchanges.

MacDonald M, Wodak AD, Ali R, Crofts N, Cunningham PH, Dolan KA, Kelaher M, Loxley WM, van Beek I, Kaldor JM. MacDonald M, et al. Among authors: dolan ka. Med J Aust. 1997 Mar 3;166(5):237-40. Med J Aust. 1997. PMID: 9076266

3

HIV transmission in a prison system in an Australian State.

Dolan KA, Wodak A. Dolan KA, et al. Med J Aust. 1999 Jul 5;171(1):14-7. doi: 10.5694/j.1326-5377.1999.tb123490.x. Med J Aust. 1999. PMID: 10451665

4

Hepatitis C virus antibody prevalence among injecting drug users at selected needle and syringe programs in Australia, 1995-1997. Collaboration of Australian NSPs.

MacDonald MA, Wodak AD, Dolan KA, van Beek I, Cunningham PH, Kaldor JM. MacDonald MA, et al. Among authors: dolan ka. Med J Aust. 2000 Jan 17;172(2):57-61. doi: 10.5694/j.1326-5377.2000.tb139199.x. Med J Aust. 2000. PMID: 10738473

5

Acute hepatitis C virus infection in an Australian prison inmate: tattooing as a possible transmission route.

Post JJ, Dolan KA, Whybin LR, Carter IW, Haber PS, Lloyd AR. Post JJ, et al. Among authors: dolan ka. Med J Aust. 2001 Feb 19;174(4):183-4. doi: 10.5694/j.1326-5377.2001.tb143214.x. Med J Aust. 2001. PMID: 11270759

6

Pilot randomized controlled study of dexamphetamine substitution for amphetamine dependence.

Shearer J, Wodak A, Mattick RP, Van Beek I, Lewis J, Hall W, Dolan K. Shearer J, et al. Among authors: dolan k. Addiction. 2001 Sep;96(9):1289-96. doi: 10.1046/j.1360-0443.2001.96912898.x. Addiction. 2001. PMID: 11672493 Clinical Trial.

7

Decreased heroin availability in Sydney in early 2001.

Day C, Topp L, Rouen D, Darke S, Hall W, Dolan K. Day C, et al. Among authors: dolan k. Addiction. 2003 Jan;98(1):93-5. doi: 10.1046/j.1360-0443.2003.00266.x. Addiction. 2003. PMID: 12492759

8

Hepatitis C transmission and HIV post-exposure prophylaxis after needle- and syringe-sharing in Australian prisons.

O'Sullivan BG, Levy MH, Dolan KA, Post JJ, Barton SG, Dwyer DE, Kaldor JM, Grulich AE. O'Sullivan BG, et al. Med J Aust. 2003 Jun 2;178(11):546-9. doi: 10.5694/j.1326-5377.2003.tb05356.x. Med J Aust. 2003. PMID: 12765501

9

Drug consumption facilities: an update since 2000.

Kimber J, Dolan K, van Beek I, Hedrich D, Zurhold H. Kimber J, et al. Among authors: dolan k. Drug Alcohol Rev. 2003 Jun;22(2):227-33. doi: 10.1080/095952301000116951. Drug Alcohol Rev. 2003. PMID: 12850909 Review.

10

Modelling hepatitis C virus incidence, prevalence and long-term sequelae in Australia, 2001.

Law MG, Dore GJ, Bath N, Thompson S, Crofts N, Dolan K, Giles W, Gow P, Kaldor J, Loveday S, Powell E, Spencer J, Wodak A. Law MG, et al. Among authors: dolan k. Int J Epidemiol. 2003 Oct;32(5):717-24. doi: 10.1093/ije/dyg101. Int J Epidemiol. 2003. PMID: 14559738

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

476 results

Search Page

Filters